rs2955384
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145691.4(ATPAF2):c.133+2622C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 151,794 control chromosomes in the GnomAD database, including 13,412 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 13412 hom., cov: 31)
Consequence
ATPAF2
NM_145691.4 intron
NM_145691.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0770
Publications
13 publications found
Genes affected
ATPAF2 (HGNC:18802): (ATP synthase mitochondrial F1 complex assembly factor 2) This gene encodes an assembly factor for the F(1) component of the mitochondrial ATP synthase. This protein binds specifically to the F1 alpha subunit and is thought to prevent this subunit from forming nonproductive homooligomers during enzyme assembly. This gene is located within the Smith-Magenis syndrome region on chromosome 17. An alternatively spliced transcript variant has been described, but its biological validity has not been determined. [provided by RefSeq, Jul 2008]
ATPAF2 Gene-Disease associations (from GenCC):
- mitochondrial proton-transporting ATP synthase complex deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex V (ATP synthase) deficiency, nuclear type 1Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.402 AC: 60988AN: 151676Hom.: 13405 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
60988
AN:
151676
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.402 AC: 61029AN: 151794Hom.: 13412 Cov.: 31 AF XY: 0.415 AC XY: 30796AN XY: 74172 show subpopulations
GnomAD4 genome
AF:
AC:
61029
AN:
151794
Hom.:
Cov.:
31
AF XY:
AC XY:
30796
AN XY:
74172
show subpopulations
African (AFR)
AF:
AC:
16804
AN:
41352
American (AMR)
AF:
AC:
7555
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1438
AN:
3470
East Asian (EAS)
AF:
AC:
4465
AN:
5140
South Asian (SAS)
AF:
AC:
3444
AN:
4796
European-Finnish (FIN)
AF:
AC:
4176
AN:
10540
Middle Eastern (MID)
AF:
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21810
AN:
67924
Other (OTH)
AF:
AC:
853
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1742
3484
5225
6967
8709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2448
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.